Deerfield Healthcare Innovations Fund, L.P.'s Net Worth

$1.7 Billion

Estimate Recalculated Feb 16, 2024 02:39PM EST

Who is Deerfield Healthcare Innovations Fund, L.P.?

Deerfield Healthcare Innovations Fund, L.P. has an estimated net worth of $1.7 Billion. This is based on reported shares across multiple companies, which include Editas Medicine, Inc., Nuvalent, Inc., Mirum Pharmaceuticals, Inc., GRAYBUG VISION, INC., Larimar Therapeutics, Inc., Homology Medicines, Inc., and Oncorus, Inc..

SEC CIK

Deerfield Healthcare Innovations Fund, L.P.'s CIK is 0001646981

Past Insider Trading and Trends

2020 was Deerfield Healthcare Innovations Fund, L.P.'s most active year for acquiring shares with 14 total transactions. Deerfield Healthcare Innovations Fund, L.P.'s most active month to acquire stocks was the month of August. 2022 was Deerfield Healthcare Innovations Fund, L.P.'s most active year for disposing of shares, totalling 39 transactions. Deerfield Healthcare Innovations Fund, L.P.'s most active month to dispose stocks was the month of November. 2020 saw Deerfield Healthcare Innovations Fund, L.P. paying a total of $40,000,000.00 for 8,130,683 shares, this is the most they've acquired in one year. In 2020 Deerfield Healthcare Innovations Fund, L.P. cashed out on 57,002,139 shares for a total of $18,052,380.80, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Editas Medicine, Inc. (EDIT) Snapshot price: $7.125

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.81M
$16.00
1.81M
Feb 8
Form 3
0
0
No matching records found

Nuvalent, Inc. (NUVL) Snapshot price: $79.33

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
650K
$33.50
$21,775,000.00
650K
Nov 3
Form 4
+3,369.86%
18.78M
19.34M
Aug 2
Form 3
0
0
No matching records found

Mirum Pharmaceuticals, Inc. (MIRM) Snapshot price: $27.21

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.17%
-38.48K
$25.01
-$962,255.52
3.24M
Jun 6
Form 4
-100.00%
-99.33K
$15.81
-$1,570,328.25
0
Jul 9
Form 4
-40.17%
-66.67K
$16.29
-$1,086,221.55
99.33K
Jul 2 - Jul 7
Form 4
3.45M
$15.00
$2,490,000.00
3.45M
Jul 22
Form 3
0
0
No matching records found

GRAYBUG VISION, INC. (CALC) Snapshot price: $5.6772

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
5.28M
$16.00
5.28M
Sep 29
Form 3
0
0
No matching records found

Larimar Therapeutics, Inc. (LRMR) Snapshot price: $5.81

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+35.11%
4.29M
$8.74
$37,499,992.58
16.51M
Feb 16
Form 4
+190.58%
11.11M
$3.15
$34,999,990.20
16.94M
Sep 16
Form 4
+13.33%
685.71K
$8.75
$5,999,962.50
5.83M
Jun 30
Form 3
0
0
No matching records found